STEPHENSON BRIAN C 4
4 · BridgeBio Pharma, Inc. · Filed Nov 19, 2024
Insider Transaction Report
Form 4
STEPHENSON BRIAN C
Secretary, Treasurer & CFO
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-11-16−6,705→ 87,164 total→ Common Stock (6,705 underlying) - Tax Payment
Common Stock
2024-11-16$23.72/sh−13,077$310,186→ 97,914 total - Exercise/Conversion
Common Stock
2024-11-16+25,799→ 110,991 total - Exercise/Conversion
Restricted Stock Units
2024-11-16−778→ 779 total→ Common Stock (778 underlying) - Exercise/Conversion
Restricted Stock Units
2024-11-16−947→ 3,786 total→ Common Stock (947 underlying) - Exercise/Conversion
Restricted Stock Units
2024-11-16−17,369→ 156,315 total→ Common Stock (17,369 underlying)
Footnotes (6)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,799 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F4]The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F5]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F6]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.